Pharming (PHAR) Acquisitions (2019 - 2026)

Pharming's (PHAR) quarterly Acquisitions came in at -$57.5 million in Q4 2025, down 131.11% on a QoQ basis from $184.8 million in Q1 2023.

Pharming (PHAR) Acquisitions (2019 - 2026) Analysis & Trends

Pharming (PHAR) has 6 years of Acquisitions data on file, last reported at -$57.5 million in Q4 2025.

Quarterly Acquisitions changed N/A year-over-year to -$57.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$62.4 million (changed N/A YoY) and the FY2025 annual result came in at -$57.5 million, changed N/A from the prior year.
Acquisitions slipped to -$57.5 million in Q4 2025, from $184.8 million in the prior quarter.
In the past five years, Acquisitions ranged from a high of $206.6 million in Q1 2021 to a low of -$190.0 million in Q3 2022.
A 4-year average of $37.3 million and a median of $290000.0 in 2022 frame the typical range for Acquisitions.
The widest YoY moves for Acquisitions: up 0.04% in 2021, down 33024.99% in 2021.
Tracing PHAR's Acquisitions over 4 years: stood at -$547000.0 in 2021, then tumbled by 34628.34% to -$190.0 million in 2022, then soared by 197.27% to $184.8 million in 2023, then tumbled by 131.11% to -$57.5 million in 2025.
The last three Acquisitions figures came in at -$57.5 million (Q4 2025), $184.8 million (Q1 2023), and -$190.0 million (Q3 2022), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	-
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	-
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-
10	Pharming	824.47 Mn	666.19 Mn	141.47 Mn	6.13 Mn

Download Data